Charles River Laboratories International (CRL) Total Non-Current Liabilities (2009 - 2025)

Charles River Laboratories International's Total Non-Current Liabilities history runs 17 years deep, the most recent figure standing at $3.8 billion for Q4 2025.

• In Q4 2025, Total Non-Current Liabilities fell 1.02% year-over-year to $3.8 billion; the TTM figure through Dec 2025 stood at $3.8 billion (down 1.02% YoY), while the FY2025 annual figure was $3.8 billion, down 1.02% from the prior year.
• Total Non-Current Liabilities for Q4 2025 stood at $3.8 billion, down from $3.9 billion in the prior quarter.
• The five-year high for Total Non-Current Liabilities was $4.6 billion in Q2 2022, with the low at $3.4 billion in Q1 2021.
• The 5-year median for Total Non-Current Liabilities is $4.2 billion (2021), against an average of $4.1 billion.
• The sharpest annual moves came in 2021 and 2024: Total Non-Current Liabilities soared 33.34% in 2021, then retreated 11.31% in 2024.
• Charles River Laboratories International's Total Non-Current Liabilities stood at $4.2 billion in 2021, then gained by 5.13% to $4.4 billion in 2022, then dropped by 2.08% to $4.3 billion in 2023, then retreated by 11.31% to $3.8 billion in 2024, then decreased by 1.02% to $3.8 billion in 2025.
• Business Quant data shows CRL's Total Non-Current Liabilities at $3.8 billion in Q4 2025, $3.9 billion in Q3 2025, and $4.0 billion in Q2 2025.